SATB2 is Consistently Expressed in Squamous Morules Associated With Endometrioid Proliferative Lesions and in the Stroma of Atypical Polypoid Adenomyoma

被引:27
作者
McCluggage, W. Glenn [1 ]
Van de Vijver, Koen [2 ]
机构
[1] Belfast Hlth & Social Care Trust, Dept Pathol, Belfast, Antrim, North Ireland
[2] Ghent Univ Hosp, CRIG, Dept Pathol, Ghent, Belgium
关键词
Endometrium; Ovary; Squamous morules; Immunohistochemistry; SATB2; Atypical polypoid adenomyoma; FEMALE GENITAL-TRACT; UTERUS; OVARY; CARCINOMA; MARKER; TUMORS;
D O I
10.1097/PGP.0000000000000544
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
So-called squamous morules are closely associated with endometrioid proliferative lesions, in the endometrium and the ovary. Morules have an unusual immunophenoptype, typically exhibiting nuclear staining with beta-catenin, positivity with CDX2, CD10, and p16 and are negative with hormone receptors and p63. We report the previously undescribed occurrence of consistent SATB2 nuclear positivity within morules. Nuclear positivity was present in 38/43 (88%) cases of morules (24 focal; 14 diffuse) while all cases of nonmorular squamous metaplasia in endometrioid proliferative lesions (n=13) were SATB2 negative, except for occasional positive nuclei in 1 case. We also observed that the stromal cells of atypical polypoid adenomyoma typically exhibited diffuse nuclear immunoreactivity with SATB2 while the stromal cells of other endometrial polypoid lesions (endometrial polyp, adenomyoma, adenosarcoma) were usually negative, although there was focal weak staining in occasional cases. Pathologists should be aware of this previously undescribed phenomenon which represents a further example of the unusual immunophenotype of so-called squamous morules. The reasons underlying SATB2 nuclear positivity in squamous morules and the stroma of atypical polypoid adenomyoma are unknown.
引用
收藏
页码:397 / 403
页数:7
相关论文
共 24 条
[1]   Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules) [J].
Brachtel, EF ;
Sánchez-Estevez, C ;
Moreno-Bueno, G ;
Prat, J ;
Palacios, J ;
Oliva, E .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (10) :1322-1329
[2]   Lesson of the Month -: CD10 is a characteristic marker of tumours forming morules with biotin-rich, optically clear nuclei that occur in different organs [J].
Cameselle-Teijeiro, J. ;
Alberte-Lista, L. ;
Chiarelli, S. ;
Buritica, C. ;
Goncalves, L. ;
Gonzalez-Campora, R. ;
Nogales, F. F. .
HISTOPATHOLOGY, 2008, 52 (03) :389-392
[3]   An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia [J].
Chiarelli, Silvia ;
Buritica, Catalina ;
Litta, Piero ;
Ciani, Susana ;
Guarch, Rosa ;
Nogales, Francisco F. .
CLINICAL CANCER RESEARCH, 2006, 12 (14) :4251-4256
[4]   Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas [J].
Davis, Jessica L. ;
Horvai, Andrew E. .
HISTOPATHOLOGY, 2016, 69 (01) :84-90
[5]  
DUTRA FR, 1959, AM J CLIN PATHOL, V31, P60
[6]   Uterine adenomyomas excluding atypical polypoid adenomyomas and adenomyomas of endocervical type: A clinicopathologic study of 30 cases of an underemphasized lesion that may cause diagnostic problems with brief consideration of adenomyomas of other female genital tract sites [J].
Gilks, CB ;
Clement, PB ;
Hart, WR ;
Young, RH .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2000, 19 (03) :195-205
[7]   Atypical polypoid adenomyoma: a systematic review of the English literature [J].
Heatley, MK .
HISTOPATHOLOGY, 2006, 48 (05) :609-610
[8]   Immunohistochemical Characteristics of Atypical Polypoid Adenomyoma With Special Reference to h-Caldesmon [J].
Horita, Ayako ;
Kurata, Atsushi ;
Maeda, Daichi ;
Fukayama, Masashi ;
Sakamoto, Atsuhiko .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2011, 30 (01) :64-70
[9]   Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2 [J].
Houghton, O. ;
Connolly, L. E. ;
McCluggage, W. G. .
HISTOPATHOLOGY, 2008, 53 (02) :156-165
[10]  
Li ZW, 2015, INT J CLIN EXP PATHO, V8, P7072